Teva Pharmaceutical Industries #TEVAAlthough the Israel Stock Exchange's TA35 index shows an uncertain future, some stocks can strongly separate themselves from it.
Next report date
Report period
Q1 2024
EPS estimate
0.51USD
Revenue estimate
3.69 BUSD
−0.45USD
−567.79 MUSD
16.10 BUSD
1.11 B
About TEVA
Sector
CEO
Richard Francis
Headquarters
Tel Aviv
Website
Employees (FY)
37.23 K
Founded
1901
ISIN
IL0006290147
FIGI
BBG000HD4X32
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
TEVA SHORT - Israel Palestine ConflictPrice points indicated on chart. Helios is shorting Teva. Looking for put options with close expiry dates.
Not financial advice
This article explores the potential implications of the ongoing Israel-Palestine conflict, which was initiated on October 7th. Teva, a global pharmaceutical giant, opera
TEVA Pharmaceutical Options Ahead of EarningsAnalyzing the options chain of TEVA Pharmaceutical prior to the earnings report this week,
I would consider purchasing the 10usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $0.55.
If these options prove to be profitable prior to the earnings release, I wo
TEVA - Double Bottom?TEVA has been a repair story now for many years. With litigation in the process of being resolved, debt burdens of $2 bn. per year appear manageable with cash flow - TEVA is moving away from a debt/litigation story
to an equity story. Cash Flow of $3bn + per year, Net Income of ~ 2bn.+.... warrant
TEVA IdeaSome symmetry in price can be seen, with the vertical line being the middle of this price symmetry in the downtrend
I foresee continuation of this downtrend for one more wave, as indicated by the red arrow
Teva: quick gains here?Teva Pharmaceutical Industries
Short Term
We look to Buy at 7.28 (stop at 7.06)
Preferred trade is to buy on dips. Previous support located at 7.20. The bias is still for higher levels and we look for any dips to be limited. Risk/Reward would be poor to call a buy from current levels.
Our p
TEVAI believe TEVA is accumulating, you can see many tops and bottoms are being liquidated. It is a whipsaw for traders in phase b. However, i believe we are going to get a test that will send us outside the range on good news
Teva Pharmaceutical Industries Analyze (Rising Wedge)!!Teva is running in Descending Channel at a daily timeframe, also Teva was able to make Rising Wedge at 4h timeframe, while we can see sell signals in MACD & RSI Indicators.
Rising Wedge's 🎯 Target 🎯: around 8$
🔴 Heavy Resistance zone : 11$ until 10.3$
Teva Pharmaceutical Indu
TEVA | SUPER BULLISHNFA - Not Financial Advice
TEVA Seem to be very bullish technically , great upside with great RR .
The upside is needed to support the Earnings that will be soon
good earning = good upside
patience is needed!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TEVJF is 11.75 USD — it has decreased by 1.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Teva Pharmaceutical Industries Ltd. stocks are traded under the ticker TEVJF.
Teva Pharmaceutical Industries Ltd. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
TEVJF stock is 1.96% volatile and has beta coefficient of 0.60. Check out the list of the most volatile stocks — is Teva Pharmaceutical Industries Ltd. there?
TEVJF earnings for the last quarter are 0.60 USD per share, whereas the estimation was 0.62 USD resulting in a −3.42% surprise. The estimated earnings for the next quarter are 0.79 USD per share. See more details about Teva Pharmaceutical Industries Ltd. earnings.
Teva Pharmaceutical Industries Ltd. revenue for the last quarter amounts to 3.87 B USD despite the estimated figure of 3.83 B USD. In the next quarter revenue is expected to reach 4.13 B USD.
Yes, you can track Teva Pharmaceutical Industries Ltd. financials in yearly and quarterly reports right on TradingView.
TEVJF stock has fallen by 1.92% compared to the previous week, the month change is a 10.98% fall, over the last year Teva Pharmaceutical Industries Ltd. has showed a 35.68% increase.
TEVJF net income for the last quarter is 486.33 M USD, while the quarter before that showed 77.40 M USD of net income which accounts for 528.36% change. Track more Teva Pharmaceutical Industries Ltd. financial stats to get the full picture.
Today Teva Pharmaceutical Industries Ltd. has the market capitalization of 14.53 B, it has decreased by 5.39% over the last week.
Like other stocks, TEVJF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Teva Pharmaceutical Industries Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 37.23 K employees. See our rating of the largest employees — is Teva Pharmaceutical Industries Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Teva Pharmaceutical Industries Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Teva Pharmaceutical Industries Ltd. stock shows the buy signal. See more of Teva Pharmaceutical Industries Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Teva Pharmaceutical Industries Ltd. future price: according to them, TEVJF price has a max estimate of 18.85 USD and a min estimate of 10.67 USD. Read a more detailed Teva Pharmaceutical Industries Ltd. forecast: see what analysts think of Teva Pharmaceutical Industries Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Teva Pharmaceutical Industries Ltd. EBITDA is 4.44 B USD, and current EBITDA margin is 27.45%. See more stats in Teva Pharmaceutical Industries Ltd. financial statements.